Results 211 to 220 of about 3,046,243 (224)

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Blood, 2007
Attilio Orazi, Giovanni Barosi, Gunnar Birgegard   +2 more
exaly  

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Leukemia, 2009
Ayalew Tefferi
exaly  

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Blood, 2012
Tiziano Barbui, Alessandra Carobbio, Francesco Passamonti   +2 more
exaly  

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Blood Cancer Journal, 2015
Ayalew Tefferi
exaly  

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

Leukemia, 2010
Ayalew Tefferi, Paola Guglielmelli, Lisa Pieri   +2 more
exaly  

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk‐stratification and management

American Journal of Hematology, 2019
Ayalew Tefferi, Tiziano Barbui
exaly  

Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia

Journal of Clinical Oncology, 2008
Alessandra Carobbio, Paola Guglielmelli, Alessandro Maria Vannucchi   +2 more
exaly  

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management

American Journal of Hematology, 2017
Ayalew Tefferi, Tiziano Barbui
exaly  

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

Blood, 2011
Alessandra Carobbio, Francesco Passamonti, Elisa Rumi   +2 more
exaly  

Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?

Blood, 2012
Hans Carl Hasselbalch
exaly